FINWIRES · TerminalLIVE
FINWIRES

Israel-Lebanon Ceasefire Extension Nudges US Equity Futures Higher Pre-Bell

-- US equity futures nudged higher pre-bell Friday as Israel and Lebanon extended their ceasefire by three weeks in a meeting at the White House facilitated by President Donald Trump.

Dow Jones Industrial Average futures were 0.1% lower, S&P 500 futures were up 0.4%, and Nasdaq futures were 1.3% lower.

Fighting between Israel and Iran-backed militant group Hezbollah in Lebanon has been a key discussion point in negotiations to end the conflict in the Middle East. The Strait of Hormuz remains effectively closed to vessels, while the US maintains its blockade on Iranian ports.

Trump said he was not in a hurry to reach a peace agreement with Iran, saying he wanted to make it "everlasting." He had extended the US-Iran ceasefire, calling the Iranian government "fractured," but Iran's Supreme Leader Ayatollah Mojtaba Khamenei on Thursday denied Trump's claim of disunity in the country's leadership.

Traders tracked the latest round of earnings, with Procter & Gamble (PG) reporting higher fiscal Q3 financial results and HCA Healthcare (HCA) posting an increase in Q1 adjusted earnings and revenue.

Oil prices were mostly flat, with front-month global benchmark North Sea Brent crude up 0.3% at $105.39 per barrel and US West Texas Intermediate crude 0.1% lower at $95.73 per barrel.

The final University of Michigan consumer sentiment report for April, scheduled at 10 am ET, is expected to show consumer sentiment index coming in at 48.5, compared with the preliminary reading of 47.6, according to estimates compiled by Bloomberg.

In other world markets, Japan's Nikkei closed 1% higher, Hong Kong's Hang Seng ended 0.2% higher, and China's Shanghai Composite finished 0.3% lower. Meanwhile, the UK's FTSE 100 was down 0.3%, and Germany's DAX index was 0.2% higher in Europe's early afternoon session.

In equities, Intel (INTC) shares rose 26% after the company reported fiscal Q1 adjusted earnings and revenue, as well as issued fiscal Q2 guidance, that surpassed analyst estimates. Advanced Micro Devices (AMD) stock was 11% higher after DA Davidson upgraded the company's stock to buy from neutral and raised its price target to $375 from $220. Procter & Gamble shares were up 2.6% after the company's fiscal Q3 financial results beat analysts' consensus.

On the losing side, HCA Healthcare shares dropped 7.8% after the company reported its Q1 financial results. Comcast (CMCSA) stock was down 2.7% after the company posted lower Q1 adjusted earnings from a year ago. Infosys (INFY) shares fell 2.6% despite reporting higher fiscal Q4 earnings and revenue.

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB